Combination therapy for hypertension

Hong Kong Medical Journal

Volumn 9, Issue 3, 2003, Pages 224-226

  Cheung, B M Y ^a   Lau, C P ^a   Kumana, C R ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROCHLOROTHIAZIDE; INDAPAMIDE; LOSARTAN; PERINDOPRIL;

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; DRUG POTENTIATION; EVIDENCE BASED MEDICINE; HONG KONG; HUMAN; HYPERTENSION; META ANALYSIS; NOTE; PATIENT COMPLIANCE;

DRUG SYNERGISM; DRUG THERAPY, COMBINATION; EVIDENCE-BASED MEDICINE; HUMANS; HYPERTENSION; PATIENT COMPLIANCE;

EID: 0038352223     PISSN: 10242708     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (23)

1. Janus ED. Epidemiology of cardiovascular risk factors in Hong Kong. Clin Exp Pharmacol Physiol 1997;24:987-8.
2. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997;157:2413-46.
3. Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 1998;351:1755-62.
4. Tight blood pressure control and risk of macrovascular and micro-vascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ 1998;317:703-13.
5. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000;342:145-53.
6. Chalmers JP. "Treating hypertension" or "lowering blood pressure"? Extending the concept. Blood Press 2002;11:68-70.
7. Du X, Cruickshank K, McNamee R, et al. Case-control study of stroke and the quality of hypertension control in north west England. BMJ 1997;314:272-6.
8. Cheung BM, Law FC, Lau CP. The rule of halves applies in Chinese hypertensive patients. Am J Hypertens 2002;15:209A.
9. Dickerson JE, Hingorani AD, Ashby MJ, Palmer CR, Brown MJ. Optimisation of antihypertensive treatment by crossover rotation of four major classes. Lancet 1999;353:2008-13.
10. Morgan TO, Anderson AI, Maclnnis RJ. ACE inhibitors, beta-blockers, calcium blockers, and diuretics for the control of systolic hypertension. Am J Hypertens 2001;14:241-7.
11. Laragh J. Laragh's lessons in pathophysiology and clinical pearls for treating hypertension. Am J Hypertens 2001;14:491-503.
12. Cheung BM, Cheung AH, Ho SP, Lau CP, Kumana CR. Utilisation of antihypertensive drugs in a hypertension clinic in 1996 & 1998. J Clin Pharmacol 1999;39(Suppl):969S.
13. Frishman WH, Bryzinski BS, Coulson LR, et al. A multifactorial trial design to assess combination therapy in hypertension. Treatment with bisoprolol and hydrochlorothiazide. Arch Intern Med 1994;154: 1461-8.
14. McClellan KJ, Markham A. Perindopril 2mg/indapamide 0.625mg. Fixed low-dose combination. Drugs 1999;58:297-302.
15. Langtry HD, McClellan KJ. Valsartan/hydrochlorothiazide. Drugs 1999;57:751-8.
16. Gradman AH, Cutler NR, Davis PJ, Robbins JA, Weiss RJ, Wood BC. Combined enalapril and felodipine extended release (ER) for systemic hypertension. Enalapril-Felodipine ER Factorial Study Group. Am J Cardiol 1997;79:431-5.
17. Widmer P, Malbach R, Kunzi UP, et al. Diuretic-related hypokalaemia:the role of diuretics, potassium supplements, glucocorticoids and beta 2-adrenoceptor agonists. Results from the comprehensive hospital drug monitoring programme, Berne (CHDM). Eur J Clin Pharmacol 1995;49: 31-6.
18. Dahlof B, Lindholm LH, Hansson L, Schersten B, Ekbom T, Wester PO. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet 1991;338:1281-5.
19. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA 1991;265:3255-64.
20. 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Sub-committee. J Hypertens 1999;17:151-83.
21. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 2001;358:1033-41.
22. Dahlof B, Devereux RB, Kjeldsen SE, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002;359:995-1003.
23. Waeber B, Brunner HR. Main objectives and new aspects of combination treatment of hypertension. J Hypertens 1985;13(Suppl):15S-9S.